Leone, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 10.848
NA - Nord America 9.812
AS - Asia 3.402
OC - Oceania 157
AF - Africa 81
SA - Sud America 80
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.388
Nazione #
US - Stati Uniti d'America 9.669
DE - Germania 5.046
CN - Cina 1.939
SE - Svezia 1.571
UA - Ucraina 1.074
IT - Italia 746
SG - Singapore 641
FR - Francia 490
GB - Regno Unito 475
IE - Irlanda 378
PL - Polonia 348
IN - India 244
FI - Finlandia 234
ID - Indonesia 219
RU - Federazione Russa 156
TR - Turchia 154
AU - Australia 133
CA - Canada 97
NL - Olanda 52
CI - Costa d'Avorio 49
BE - Belgio 48
JP - Giappone 44
ES - Italia 41
MX - Messico 35
BR - Brasile 30
AR - Argentina 28
IR - Iran 28
NZ - Nuova Zelanda 24
CH - Svizzera 22
HK - Hong Kong 21
RO - Romania 21
VN - Vietnam 20
KR - Corea 19
HU - Ungheria 14
NO - Norvegia 14
AT - Austria 13
CZ - Repubblica Ceca 12
GR - Grecia 12
BG - Bulgaria 11
PT - Portogallo 11
AE - Emirati Arabi Uniti 9
SK - Slovacchia (Repubblica Slovacca) 9
IL - Israele 8
LT - Lituania 8
DZ - Algeria 7
EG - Egitto 7
EU - Europa 7
HR - Croazia 7
ZA - Sudafrica 7
CL - Cile 6
CO - Colombia 6
LV - Lettonia 6
TH - Thailandia 6
LB - Libano 5
LU - Lussemburgo 5
MK - Macedonia 5
MY - Malesia 5
RS - Serbia 5
SA - Arabia Saudita 5
BD - Bangladesh 4
BZ - Belize 4
MA - Marocco 4
NP - Nepal 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CR - Costa Rica 3
EE - Estonia 3
GH - Ghana 3
JO - Giordania 3
UY - Uruguay 3
BO - Bolivia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
GE - Georgia 2
IS - Islanda 2
MM - Myanmar 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
QA - Qatar 2
SD - Sudan 2
A1 - Anonimo 1
AM - Armenia 1
AZ - Azerbaigian 1
CY - Cipro 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 24.388
Città #
Chandler 1.609
Ashburn 708
Jacksonville 699
Singapore 514
Nanjing 454
San Mateo 451
Dearborn 448
Dublin 366
Ann Arbor 352
Nürnberg 335
Warsaw 314
Woodbridge 272
Houston 271
Wilmington 249
Beijing 209
Jakarta 209
Milan 196
New York 187
Seattle 186
Hangzhou 182
Nanchang 179
Redwood City 154
Lawrence 148
Munich 142
Izmir 133
Los Angeles 133
Bremen 131
Boston 129
Marseille 120
Fairfield 107
Moscow 107
Kunming 101
Lancaster 101
Cattolica 81
Shenyang 81
Zhengzhou 73
University Park 67
Hebei 63
Tianjin 62
Leawood 59
Chicago 58
Princeton 57
Mountain View 56
Rome 53
Guangzhou 52
Abidjan 49
Changsha 48
Hefei 48
Auburn Hills 47
Redmond 47
Jiaxing 46
Norwalk 46
Boardman 42
Brussels 42
Shanghai 41
Cambridge 37
Philadelphia 36
Pune 36
Jinan 35
Fremont 34
Sydney 31
Augusta 28
Helsinki 28
London 27
Phoenix 25
San Diego 24
Buffalo 23
Detroit 23
Lanzhou 23
Melbourne 23
Simi Valley 23
Adelaide 22
Brisbane 22
Portland 22
San Francisco 22
Toronto 22
Changchun 21
Chatsworth 19
San Jose 19
Hong Kong 18
Brooklyn 17
Hanoi 17
Wayne 17
Berlin 16
Costa Mesa 16
Federal 16
Mexico 16
Tobarra 16
Washington 16
Amsterdam 15
Frankfurt am Main 15
Ningbo 14
Santa Clara 14
Taizhou 14
Indiana 13
Verona 13
Ypsilanti 13
Auckland 12
Falls Church 12
Kocaeli 11
Totale 12.050
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.315
Incidence of acute myeloid leukemia after breast cancer 336
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 305
Factors associated with mortality in bacteremic patients with haematologic malignancies 300
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 231
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 230
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 229
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 221
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 211
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 206
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 199
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 187
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 184
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 175
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 175
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 171
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 169
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 168
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 166
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 159
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 157
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 157
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 155
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 154
Von hippel-lindau disease and erythrocytosis 151
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 148
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 144
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 140
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 139
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 138
Why methylation is not a marker predictive of response to hypomethylating agents 137
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 136
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 135
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 133
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 133
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 133
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 133
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 132
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 130
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 130
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 130
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 129
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 129
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 128
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 128
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 128
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 127
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 125
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 124
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 124
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 124
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 123
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 123
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 122
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 121
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 121
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 120
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 120
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 119
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 118
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 117
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 117
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 117
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 117
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 116
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 116
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 116
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 115
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 114
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 113
Primary plasma cell leukemia followed by testicular plasmacytoma 113
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 113
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 111
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 111
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 110
Iron in Hodgkin's lymphoma 110
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 110
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 109
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 108
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 108
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 107
Epigenetic changes in therapy-related MDS/AML 107
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 107
Similarities and differences between therapy-related and elderly acute myeloid leukemia 107
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 107
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 107
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 106
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 105
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 104
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 104
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 104
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 104
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 103
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 103
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 103
Totale 16.127
Categoria #
all - tutte 76.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.521 0 0 0 0 404 491 360 154 295 267 277 273
2020/20212.596 94 279 64 242 293 211 322 59 286 155 526 65
2021/20222.084 219 240 37 106 138 77 53 345 85 137 283 364
2022/20234.368 520 641 333 725 310 530 225 344 510 46 118 66
2023/20242.558 103 573 87 110 149 387 124 104 102 178 358 283
2024/20251.574 322 249 398 180 425 0 0 0 0 0 0 0
Totale 24.518